These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28882312)

  • 21. Pseudo-phosphorylation of tau at Ser202 and Thr205 affects tau filament formation.
    Rankin CA; Sun Q; Gamblin TC
    Brain Res Mol Brain Res; 2005 Jul; 138(1):84-93. PubMed ID: 15913837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered tubulin assembly dynamics with N-homocysteinylated human 4R/1N tau in vitro.
    Karima O; Riazi G; Khodadadi S; Aryapour H; Khalili MA; Yousefi L; Moosavi-Movahedi AA
    FEBS Lett; 2012 Nov; 586(21):3914-9. PubMed ID: 23041345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening.
    Crespo R; Koudstaal W; Apetri A
    J Vis Exp; 2018 Nov; (141):. PubMed ID: 30531722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On-chip microtubule gliding assay for parallel measurement of tau protein species.
    Subramaniyan Parimalam S; Tarhan MC; Karsten SL; Fujita H; Shintaku H; Kotera H; Yokokawa R
    Lab Chip; 2016 Apr; 16(9):1691-7. PubMed ID: 27056640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy.
    Hogg M; Grujic ZM; Baker M; Demirci S; Guillozet AL; Sweet AP; Herzog LL; Weintraub S; Mesulam MM; LaPointe NE; Gamblin TC; Berry RW; Binder LI; de Silva R; Lees A; Espinoza M; Davies P; Grover A; Sahara N; Ishizawa T; Dickson D; Yen SH; Hutton M; Bigio EH
    Acta Neuropathol; 2003 Oct; 106(4):323-36. PubMed ID: 12883828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tau isoform composition influences rate and extent of filament formation.
    Zhong Q; Congdon EE; Nagaraja HN; Kuret J
    J Biol Chem; 2012 Jun; 287(24):20711-9. PubMed ID: 22539343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter.
    Zhukareva V; Mann D; Pickering-Brown S; Uryu K; Shuck T; Shah K; Grossman M; Miller BL; Hulette CM; Feinstein SC; Trojanowski JQ; Lee VM
    Ann Neurol; 2002 Jun; 51(6):730-9. PubMed ID: 12112079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional differences of tau isoforms containing 3 or 4 C-terminal repeat regions and the influence of oxidative stress.
    Utton MA; Gibb GM; Burdett ID; Anderton BH; Vandecandelaere A
    J Biol Chem; 2001 Sep; 276(36):34288-97. PubMed ID: 11438517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The microtubule-associated protein tau in neurodegenerative diseases. Tauopathies].
    Sánchez MP; Alvarez-Tallada V; Avila J
    Rev Neurol; 2001 Jul 16-31; 33(2):169-77. PubMed ID: 11562878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Under Heparin-Free Conditions Unsaturated Phospholipids Inhibit the Aggregation of 1N4R and 2N4R Tau.
    Ali A; Matveyenka M; Rodriguez A; Kurouski D
    J Phys Chem Lett; 2024 Aug; 15(33):8577-8583. PubMed ID: 39140785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developmental regulation of alternatively spliced isoforms of mRNA encoding MAP2 and tau in rat brain oligodendrocytes during culture maturation.
    Richter-Landsberg C; Gorath M
    J Neurosci Res; 1999 May; 56(3):259-70. PubMed ID: 10336255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryo-EM structures of tau filaments.
    Scheres SH; Zhang W; Falcon B; Goedert M
    Curr Opin Struct Biol; 2020 Oct; 64():17-25. PubMed ID: 32603876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atomic Force Microscopy Imaging and Nanomechanical Properties of Six Tau Isoform Assemblies.
    Makky A; Bousset L; Madiona K; Melki R
    Biophys J; 2020 Dec; 119(12):2497-2507. PubMed ID: 33217380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trichloroacetic acid treatment as a tricky way for rapid purification of 1N/4R tau protein.
    Asadollahi K; Rafiee S; Riazi GH; Pooyan S; Afrasiabi A
    Protein Expr Purif; 2016 Feb; 118():98-104. PubMed ID: 26481271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of microtubule dynamics by tau in living cells: implications for development and neurodegeneration.
    Bunker JM; Wilson L; Jordan MA; Feinstein SC
    Mol Biol Cell; 2004 Jun; 15(6):2720-8. PubMed ID: 15020716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligand-dependent inhibition and reversal of tau filament formation.
    Chirita C; Necula M; Kuret J
    Biochemistry; 2004 Mar; 43(10):2879-87. PubMed ID: 15005623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of annealing and fragmentation in human tau aggregation dynamics.
    Huseby CJ; Bundschuh R; Kuret J
    J Biol Chem; 2019 Mar; 294(13):4728-4737. PubMed ID: 30745358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tau 6D and 6P isoforms inhibit polymerization of full-length tau in vitro.
    Lapointe NE; Horowitz PM; Guillozet-Bongaarts AL; Silva A; Andreadis A; Binder LI
    Biochemistry; 2009 Dec; 48(51):12290-7. PubMed ID: 19919107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro aggregation assays using hyperphosphorylated tau protein.
    Sui D; Liu M; Kuo MH
    J Vis Exp; 2015 Jan; (95):e51537. PubMed ID: 25590418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible role of each repeat structure of the microtubule-binding domain of the tau protein in in vitro aggregation.
    Tomoo K; Yao TM; Minoura K; Hiraoka S; Sumida M; Taniguchi T; Ishida T
    J Biochem; 2005 Oct; 138(4):413-23. PubMed ID: 16272135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.